“…These BBB regional differences in response to damage (Kuriakose, Rama Rao, Younger, & Chandra, 2018;Mastorakos & McGavern, 2019) or hypertonicity (Rapoport et al, 1980;Stonestreet et al, 2006) have been widely studied. Similarly, it is well known that besides the Hyp (Smyth, Natarajan, & Wilkinson, 1997), also the cerebral cortex and Hp highly susceptible regions to neonatal MSG treatment (Chaparro-Huerta, Rivera-Cervantes, Flores-Soto, Gómez-Pinedo, & Beas-Zárate, 2005; Chaparro-Huerta, Rivera-Cervantes, Torres-Mendoza, & Beas-Zárate, 2002;Rivera-Cervantes et al, 2009;Ureña-Guerrero et al, 2009). The susceptibility to neonatal excitotoxicity of these cerebral regions is mainly due to low expression level of glutamate transporters (Rose, Ziemens, Untiet, & Fahlke, 2018) and high expression level of glutamate receptors (Shinohara & Hirase, 2009;Somogyi, Tamás, Lujan, & Buhl, 1998)…”